Literature DB >> 19953015

[Validation study of the BDI/TDI scores in chronic obstructive pulmonary disease].

C Laurendeau1, C Pribil, T Perez, N Roche, M-C Simeoni, B Detournay.   

Abstract

BACKGROUND: The Baseline and Transition Dyspnoea Indices (BDI/TDI) provide measurements of breathlessness and of its impact on activities of daily living.
OBJECTIVES: To assess, in France, the measurement characteristics of the BDI/TDI scores.
METHOD: A multicentric cohort of 103 patients with mild to severe COPD was questioned by both a medical and a paramedical investigator at enrollment and again 6 months later.
RESULTS: Concordance between investigators was good for all the sub-scores of the BDI, but less satisfactory for the TDI score. The BDI score was significantly correlated with all spirometric data. Conversely, the TDI score only correlated significantly with change in the FEV1. Both scores correlated highly with the modified Medical Research Council score, the St George Respiratory Questionnaire and with their evolution. The average TDI score was close to 0 in stable patients indicating good reproducibility of this Index. Changes in the TDI score were closely associated with changes in global health assessment by physicians, less so when assessed by patients.
CONCLUSION: The BDI-TDI scores appear to be valid instruments for the measurement of dyspnoea in COPD patients and, less significantly, for measurement of its change over time.

Entities:  

Mesh:

Year:  2009        PMID: 19953015     DOI: 10.1016/s0761-8425(09)72424-6

Source DB:  PubMed          Journal:  Rev Mal Respir        ISSN: 0761-8425            Impact factor:   0.622


  3 in total

Review 1.  Umeclidinium Plus Vilanterol Versus Placebo, Umeclidinium, or Vilanterol Monotherapies for Chronic Obstructive Pulmonary Disease: A Meta-Analysis of Randomized Controlled Trials.

Authors:  Li Wang; Chun-Juan Zhai; Yao Liu; Yi Liu; Shu-Juan Jiang
Journal:  Clin Drug Investig       Date:  2016-11       Impact factor: 2.859

2.  Modified Medical Research Council scale vs Baseline Dyspnea Index to evaluate dyspnea in chronic obstructive pulmonary disease.

Authors:  Thierry Perez; Pierre Régis Burgel; Jean-Louis Paillasseur; Denis Caillaud; Gaetan Deslée; Pascal Chanez; Nicolas Roche
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-08-18

3.  Management of Malignant Pleural Effusion with ASEPT® Pleural Catheter: Quality of Life, Feasibility, and Patient Satisfaction.

Authors:  Inderdeep Dhaliwal; Masoud Mahdavian; Shabnam Asghari; Benson Chun To Wong; Rosalie Labelle; Kayvan Amjadi
Journal:  Can Respir J       Date:  2016-12-15       Impact factor: 2.409

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.